Vanessa Mack (Dean) will monitor your progress closely and adjust your treatment as needed to ensure optimal results
Licensed clinician review
This safety profile, demonstrated across multiple clinical trials for metabolic applications, may make it suitable for long-term joint support applications without the risks associated with traditional GH therapy
Product Specifications Research Overview Melanotan I, also written Melanotan 1 or MT1, is the linear tridecapeptide [Nle, D-Phe]-alpha-melanocyte-stimulating hormone, catalogued in the literature as afamelanotide and as NDP-alpha-MSH, sequence Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH (CHNO, 1646.9 g/mol, CAS 75921-69-6)
Below, well discuss it in more detail